Acute Lymphoblastic Leukemia with Bcr-abl1

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-07-17
Clinical Trial Update: Phase I/II Study of Bosutinib in Combination With Inotuzumab Ozogamicin in CD22-positive PC Positive ALL and CML [Phase 1, Phase 2]
Phase I/II study evaluating bosutinib combined with inotuzumab ozogamicin in CD22-positive ALL and CML showed completed status with results …